Pazopanib

From WikiMD.org
Jump to navigation Jump to search

Pazopanib

Pazopanib (pronounced pah-zoh-PAN-ib) is a type of antineoplastic agent used in the treatment of certain types of cancer, including renal cell carcinoma and soft tissue sarcoma.

Etymology

The name "Pazopanib" is derived from the combination of the words "pazo", which is a prefix used in pharmaceutical naming to denote a drug's function, and "anib", which is a suffix used to denote a drug's class. In this case, "pazo" refers to the drug's function as a tyrosine kinase inhibitor, and "anib" denotes its class as an angiogenesis inhibitor.

Usage

Pazopanib is used to treat advanced renal cell carcinoma (RCC) and advanced soft tissue sarcoma (STS) in patients who have received prior chemotherapy. It works by blocking the action of an abnormal protein that signals cancer cells to multiply, helping to slow or stop the spread of cancer cells.

Side Effects

Common side effects of Pazopanib include nausea, diarrhea, changes in hair color, and high blood pressure. Serious side effects can include liver problems, heart failure, and a type of high blood pressure called hypertension.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski